<DOC>
	<DOCNO>NCT02579889</DOCNO>
	<brief_summary>The study design multi-center , international , prospective , parallel , randomized , single blind trial comparing time first primary endpoint event ( Sustained Paroxysmal AF/Persistent AF stroke/TIA ) occurrence follow period 3 year , Closed Loop Stimulation ( CLS ) ON versus OFF , top DDD pacing patient pacemaker ICD indication require dual-chamber pacing due sinus node disease ( SND ) , without atrioventricular ( AV ) block .</brief_summary>
	<brief_title>Clinical Benefits Closed Loop Stimulation Sinus Node Disease</brief_title>
	<detailed_description>The benefit rate-responsiveness top dual-chamber pacing still need definitively assessed Sinus Node Dysfunction ( SND ) . Although many rate responsive ( RR ) sensor develop , large clinical trial evaluate benefit term clinical endpoint clinically relevant atrial fibrillation ( AF ) stroke . Electromechanical sensor ( piezoelectric accelerometer ) widely use simplicity overall reliability . However evidence indicate Closed Loop Stimulation one efficient physiological sensor . Two randomized clinical study conduct far , show Brady-Tachy Syndrome CLS algorithm associate significantly low overall atrial arrhythmia burden compare DDDR mode base standard accelerometric sensor atrial overdrive approach . Both study yield consistent result , albeit parallel intraindividual comparison design , respectively . The atrial arrhythmic burden important surrogate endpoint , necessarily relate long-term clinical outcome . The CLS effect AF ( ) investigate term time first new onset clinically relevant AF . In light consideration , appear interesting run large randomize study coherently collect data overall clinical benefit CLS , primarily term AF stroke , population indicate pacemaker ICD need dual-chamber pacing due SND .</detailed_description>
	<mesh_term>Sick Sinus Syndrome</mesh_term>
	<criteria>Patients Class I II recommendation permanent pace due SND , without AV block accord current guideline ; Patients dualchamber pace indicate preferred ; Patients optimize stable antiarrhythmic medical therapy time enrolment ; Closed Loop Stimulation function previously activate ; No stroke event implant ; Patient implant first time ; Permanent AF ( PermAF ) NYHA Class IV Heart Failure Stage V kidney dysfunction Any indication Cardiac Resynchronization Therapy ( CRT ) Life expectancy &lt; 1 Minors Pregnant breastfeed patient Participation another interventional trial Atrial fibrillation ablation ( left pulmonary vein ) cardiac surgery &lt; 3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Closed Loop Stimulation</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Stroke</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Pacemaker</keyword>
	<keyword>ICD</keyword>
</DOC>